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Proteus mirabilis is a Gram-negative enteric pathogen that is linked to a variety of hospital-acquired illnesses ([@B1]). It is intrinsically resistant to nitrofurantoin and tetracycline ([@B1]) and has been reported to have developed resistance to extended-spectrum cephalosporins and coresistance to other antibiotics due to the production of β-lactamases ([@B2], [@B3]). The study of phages infecting P. mirabilis may lead to alternative treatments for these antibiotic-resistant strains.

Phage Mydo was isolated from a wastewater sample collected from College Station, TX, in 2013 using a Proteus mirabilis isolate as the host. Host bacteria were cultured on nutrient broth or agar (Difco) at 37°C with aeration. Phages were cultured and propagated using the soft agar overlay method ([@B4]). It was identified as a myophage using negative-stain transmission electron microscopy performed at the Texas A&M University Microscopy and Imaging Center, as described previously ([@B5]). Phage genomic DNA was prepared using a modified Promega Wizard DNA cleanup kit protocol, as described previously ([@B5]). Pooled indexed DNA libraries were prepared using the Illumina TruSeq Nano low-throughput (LT) kit, and the sequence was obtained from the Illumina MiSeq platform using the MiSeq V2 500-cycle reagent kit, following the manufacturer's instructions, producing 1,112,580 paired-end reads for the index containing the phage Mydo genome. FastQC 0.11.5 (<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>) was used to quality control the reads. The reads were trimmed with FASTX-Toolkit 0.0.14 (<http://hannonlab.cshl.edu/fastx_toolkit/download.html>) before being assembled using SPAdes 3.5.0 ([@B6]). Contig completion was confirmed by PCR using primers (5′-GGTGTCTGGTACGTTGGTTC-3′ and 5′-TGTGTGTGACAACGTACCTG-3′) facing off the ends of the assembled contig and Sanger sequencing of the resulting product, with the contig sequence manually corrected to match the resulting Sanger sequencing read. Glimmer 3.0 ([@B7]) and MetaGeneAnnotator 1.0 ([@B8]) were used to predict protein-coding genes with manual verification, and tRNA genes were predicted with ARAGORN 2.36 ([@B9]). Rho-independent terminators were identified via TransTermHP v2.09 (<http://transterm.cbcb.umd.edu/>). Sequence similarity searches were performed by BLASTp 2.2.28 ([@B10]) with a maximum expectation cutoff of 0.001 against the NCBI nonredundant (nr), UniProt Swiss-Prot ([@B11]), and TrEMBL databases. InterProScan 5.15-54.0 ([@B12]), LipoP ([@B13]), and TMHMM v2.0 ([@B14]) were used to predict protein function. All analyses were conducted at default settings via the CPT Galaxy ([@B15]) and Web Apollo ([@B16]) interfaces (<https://cpt.tamu.edu/galaxy-pub>).

Phage Mydo was assembled at 81-fold coverage to a complete genome of 145,127 bp. Mydo has a G+C content of 45%, which is higher than that of its host (39%) ([@B17]). At both the nucleotide level and protein level determined by BLAST against the NCBI nr/nucleotide database (E value, \<0.001), Mydo is closely related to Klebsiella phages vB_KpnM_BIS47 (GenBank accession number [KY652726](https://www.ncbi.nlm.nih.gov/nuccore/KY652726)) and vB_KpnM_KB57 (GenBank accession number [KT934943](https://www.ncbi.nlm.nih.gov/nuccore/KT934943)). Mydo shares 86% and 83% DNA similarity and 230 and 223 proteins (out of 264 total predicted proteins in Mydo) with phage vB_KpnM_BIS47 and phage vB_KpnM_KB57, respectively. With 77 shared proteins (determined via BLASTp; E value, \<0.001), phage Mydo is also distantly related to Escherichia coli phage rv5 (GenBank accession number [NC_011041](https://www.ncbi.nlm.nih.gov/nuccore/NC_011041)) ([@B18]), placing it within a cluster of large, virulent myophages that infect Gram-negative hosts.
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The genome sequence of phage Mydo was submitted to GenBank as accession number [MK024806](https://www.ncbi.nlm.nih.gov/nuccore/MK024806). The associated BioProject, SRA, and BioSample accession numbers are [PRJNA222858](https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA222858), [SRR8771451](https://www.ncbi.nlm.nih.gov/sra/?term=SRR8771451), and [SAMN11234226](https://www.ncbi.nlm.nih.gov/biosample/SAMN11234226), respectively.
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